Dimitri Grigoriadis
Chief Tech/Sci/R&D Officer chez NEUROCRINE BIOSCIENCES, INC.
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Kevin Gorman | M | 66 | 32 ans | |
Gary Lyons | M | 73 | 31 ans | |
William Rastetter | M | 76 | 14 ans | |
Stephen Sherwin | M | 75 | 25 ans | |
Johanna Mercier | F | 54 | 3 ans | |
Darin Lippoldt | M | 58 | 10 ans | |
Christine Poon | F | 71 | 1 ans | |
Richard Pops | M | 62 | 26 ans | |
Leslie Norwalk | F | 58 | 26 ans | |
Shalini Sharp | F | 49 | 4 ans | |
George Morrow | M | 72 | 9 ans | |
Bill Wilson | M | - | 28 ans | |
Jude Onyia | M | 60 | 3 ans | |
Todd Tushla | M | - | - | |
David Boyer | M | 44 | 5 ans | |
Haig P. Bozigian | M | 66 | 27 ans | |
Eiry Roberts | M | 60 | 6 ans | |
Matthew Abernethy | M | 44 | 7 ans | |
Kyle Gano | M | 50 | 13 ans | |
Eric Benevich | M | 58 | 9 ans | |
Julie Cooke | F | 57 | 7 ans | |
Ingrid Delaet | M | 58 | 3 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Errol de Souza | M | 70 | 6 ans | |
David-Alexandre C. Gros | M | 51 | - | |
Joseph A. Mollica | M | 83 | 20 ans | |
Corinne Nevinny | F | 64 | 14 ans | |
W. Thomas Mitchell | M | 77 | 14 ans | |
Alfred Sandrock | M | 67 | 5 ans | |
Patricia Lady | F | 65 | 2 ans | |
Lawrence Steinman | M | 76 | 8 ans | |
Scott Struthers | M | 62 | 10 ans | |
Paul W. Hawran | M | 71 | 14 ans | |
Richard Ranieri | M | 71 | 3 ans | |
Margaret E. Valeur-Jensen | M | 67 | - | |
Yun Fei Zhu | M | - | 12 ans | |
Stefan Proniuk | M | 53 | 6 ans | |
Daljit Singh Aurora | M | 55 | 1 ans | |
Joseph M. Fortunak | M | 69 |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | 7 ans |
Michelle Martin | F | - | 5 ans | |
Stephen Betz | M | 58 | 6 ans | |
Zachary Hornby | M | 45 | 2 ans | |
Yang Sai | M | - | 5 ans | |
William Mccarthy | M | - | 1 ans | |
Ajay Madan | M | 56 | 3 ans | |
Niel C. Hoglen | M | - | 2 ans | |
Howard Birndorf | M | 74 | 5 ans | |
Stefen A. Boehme | M | - | 8 ans | |
Chrysa Mineo | F | 59 | 12 ans | |
Paula Swain | F | 66 |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | 9 ans |
Robert J. Little | M | 74 | 3 ans | |
Christopher Flint O'Brien | M | 67 | 13 ans | |
Tim Coughlin | M | 57 | 15 ans | |
Wendell Wierenga | M | 76 | 4 ans | |
Adrian Adams | M | 73 | 2 ans | |
Henry Y. Pan | M | 77 | 5 ans | |
John W. Beck | M | 64 | 4 ans | |
Malcolm C. Lloyd-Smith | M | 68 | 9 ans | |
Thomas J. Joyce | M | 64 | 2 ans | |
Ebun Garner | M | 52 | 2 ans | |
Peter R. Young | M | 71 |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | 10 ans |
Barbara M. Finn | F | - | - | |
Carol A. Baum | F | 65 | 5 ans | |
Stephen G. Marcus | M | - | 2 ans | |
Brenda Van Vreeswyk | F | - | 6 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 64 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Dimitri Grigoriadis
- Réseau Personnel